Chicago, IL
Saturday, September 11, 2010
Park Hyatt Chicago
800 North Michigan Ave
Registration Closed

Ft. Lauderdale, FL
Saturday, September 25, 2010
Marriott Ft. Lauderdale-North
6650 North Andrews Ave
Registration Closed

Los Angeles, CA
Saturday, October 9, 2010
Hyatt Century Plaza
2025 Ave of the Stars
Registration Closed

Dallas, TX
Saturday, October 23, 2010
Dallas Marriott Quorum
14901 Dallas Parkway

Activity Overview
Pain is one of the most common reasons patients seek medical attention. Often pain has no cure, and left untreated, it may affect many areas of life. The condition is difficult to diagnose and manage because an individual’s perception of his or her pain is subjective, and the cause varies from patient to patient. Chronic pain, in particular, can lead to desperation, addiction, and diversion. There is a need for effective pain relief while minimizing the potential for abuse and diversion. Several novel therapeutic strategies have been developed and provide additional opportunities to effectively manage both acute and chronic pain. Pharmacists can optimize treatment strategies, as well as provide physicians and staff with important information regarding the administration, side effects, drug interaction potential, and efficacy of pharmacologic agents used to address pain. They are readily available to patients and fellow colleagues for questions regarding pain management and are often the most accessible, approachable, and trusted members of the healthcare team. In order to continue to provide this type of care, pharmacists need a detailed understanding of all aspects of pain management. This will build on the pharmacist’s in-depth knowledge by providing competence and performance learning, which will ultimately lead to practice changes and improved patient outcomes.


8:00 – 8:30 AM Registration and Light Breakfast
8:30 – 9: 30 AM Treatment of Pain: Current Concepts
9:30 – 9:40 AM Q&A/Meet with the Faculty
9:40 – 10:50 AM Evidence and Interactive Case Study Discussion/Debate Breakout Sessions
Track 1: Community Pharmacists: Legal Issues—Controlled Substances, REMS, and Diversion

Track 2: Institutional Pharmacists: Legal Issues—Controlled Substances and Pharmacoeconomic Issues
10:50 – 11:00 AM Q&A/Meet with the Faculty
11:10 – 11:30 AM Concluding Remarks, Final Q&A, and Post-Test

All attendees reconvene in main hall

This regional meeting series is designed to improve pharmacists’ quality of care by enhancing their understanding of the issues surrounding pain management in various clinical settings, raising awareness of quality measures, and how to incorporate that learning into their daily practices to improve patient outcomes.

Intended Audience
This activity is designed for pharmacists. No prerequisites required.

Learning Objectives
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. Upon the conclusion of this activity, the participant should be able to:

  • Have increased knowledge regarding:
    - Current and emerging data regarding pain management strategies in patients with acute and/or chronic pain.

    - Application of this knowledge in various pharmacy practice settings.

    - The available abuse-deterrent formulations to discourage aberrant behavior.
  • Have increased confidence in their ability to:
    - Recognize pain that may be mismanaged or undertreated.

    - Approach patients—not stereotyping/stigmatizing opiate users.

    - Uphold legal obligations associated with dispensing controlled substances for the management of pain from the pharmacist’s perspective.

    - Communicate with patients and/or prescribers to improve pain management and minimize abuse/misuse.
  • Increase their planned frequency of use (as compared with their current frequency of use) of the following:
    - Urine drug testing.

    - Assessment of the “Four A’s” of pain medicine:

    - Analgesia, activity, adverse effects, and aberrant behavior.
  • Self-report increased frequency of use of the same clinical practice strategies as shown in the above 3 objectives, and self-report observations of positive patient outcomes based on their new/increased use of these pain management strategies.
  • Increase dialog and participation in the development process of upcoming regulations for the dispensing of opioids in pharmacy practices by:
    - Reading publications on the topic.

    - Attending meetings within your institution or local area regarding upcoming current and emerging regulations.

    - Educating colleagues on responsibilities of the pharmacist with regard to opioid safety and proper prescribing.

Accreditation Statement
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education to provide continuing education for pharmacists.

Credit Designation Statement
This application-based activity is sponsored by The University of Tennessee College of Pharmacy who is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this application-based educational activity will provide 3.0 contact hours credit (0.3 CEUs). A statement of CPE credit will be mailed within 4 weeks following successful completion of the educational activity. Successful completion includes attending the session, signing the attendance sheet, and completion of the educational activity evaluation form. ACPE Program #064-000-10-210-L01-P.

Steering Committee
J. Richard Brown, PharmD, FASHP (Chair)
Professor, Department of Clinical Pharmacy
Colleges of Pharmacy and Medicine
University of Tennessee
Memphis, Tennessee

Robert L. Barkin, PharmD, MBA, FCP, DAAPM
Professor, Rush Medical College
Faculty of Anesthesiology, Family Medicine, and Pharmacology
Rush University Medical Center
Clinical Pharmacologist, Northshore University Health System—Skokie, Evanston Hospitals, Pain Centers, and The Department of Anesthesiology
Chicago, Illinois
Northshore University Health System - Skokie, Evanston, Glenbrook, Highland Park Hospitals
Pain Centers, and The Department of Anesthesiology

Bruce R. Canaday, PharmD, BCPS, FASHP, FAPhA
Chairman, Department of Pharmacy Practice and Pharmacy Administration
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, Pennsylvania

Policy on Faculty and Provider Disclosure
It is the policy of The University of Tennessee College of Pharmacy that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during the presentation(s). Detailed disclosures will be made in the course handout materials.

Americans with Disabilities Act (ADA)
The University of Tennessee College of Pharmacy fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Grievance Policy
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of an educational activity sponsored or cosponsored by The University of Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.

Fee Information
There is no fee for this educational activity.

Supported by an educational grant from PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil-Janssen Scientific Affairs, LLC.
Home | Contact Us | View Account | Need Help? | Subscription